日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapy

T细胞免疫检查点抑制剂联合低甲基化治疗局部晚期HER2阴性乳腺癌:一项地西他滨联合帕博利珠单抗序贯标准新辅助化疗的II期新辅助窗口期试验

Harry D Bear ,Xiaoyan Deng ,Dipankar Bandyopadhyay ,Michael Idowu ,Taylor M Jenkins ,Maciej Kmieciak ,Monique Williams ,Giovanni Archer ,Lindsey Gwaltney ,Patrick Dillon ,Daniel Flora ,Daniel Stover ,Andrew S Poklepovic ,Mary Hackney ,Masey Ross ,Hetal Vachhani ,Raphael Louie ,Kandace P McGuire ,Amelia Grover ,Tasnim Rahman ,Amber Hendrix